Alignment Healthcare Inc [ALHC] stock is trading at $11.70, up 1.21%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ALHC shares have gain 7.93% over the last week, with a monthly amount drifted -6.77%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Alignment Healthcare Inc [NASDAQ: ALHC] stock has seen the most recent analyst activity on December 03, 2024, when Stephens upgraded its rating to a Overweight and also boosted its price target to $17 from $13. On May 30, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $11 on the stock. Robert W. Baird started tracking the stock assigning a Outperform rating and suggested a price target of $10 on May 30, 2024. Piper Sandler upgraded its rating to a Overweight and raised its price target to $8 on May 08, 2024. Barclays started tracking with a Underweight rating for this stock on March 06, 2024, and assigned it a price target of $4.50. In a note dated March 06, 2024, Piper Sandler downgraded an Neutral rating on this stock and revised its target price from $12 to $6.
Alignment Healthcare Inc [ALHC] stock has fluctuated between $4.46 and $14.25 over the past year. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Alignment Healthcare Inc [NASDAQ: ALHC] shares were valued at $11.70 at the most recent close of the market. An investor can expect a potential drop of -14.53% based on the average ALHC price forecast.
Analyzing the ALHC fundamentals
Alignment Healthcare Inc [NASDAQ:ALHC] reported sales of 2.47B for the trailing twelve months, which represents a growth of 51.61%. Gross Profit Margin for this corporation currently stands at 0.1% with Operating Profit Margin at -0.05%, Pretax Profit Margin comes in at -0.06%, and Net Profit Margin reading is -0.06%. To continue investigating profitability, this company’s Return on Assets is posted at -0.21, Equity is -1.1 and Total Capital is -0.36. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.85.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.47 points at the first support level, and at 11.25 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.98, and for the 2nd resistance point, it is at 12.27.
Ratios To Look Out For
For context, Alignment Healthcare Inc’s Current Ratio is 1.60. Considering the valuation of this stock, the price to sales ratio is 0.92, the price to book ratio is 19.57.
Transactions by insiders
Recent insider trading involved Maroney Dawn Christine, President, Markets, that happened on Dec 16 ’24 when 30000.0 shares were sold. Officer, DAWN CHRISTINE MARONEY completed a deal on Dec 16 ’24 to buy 90000.0 shares. Meanwhile, Chief Executive Officer KAO JOHN E sold 90000.0 shares on Dec 11 ’24.
